Comparison of erector spinae plane block and tramadol on postoperative systemic immune-inflammatory response in breast cancer surgery: A prospective randomized controlled trial
- PMID: 40958235
- PMCID: PMC12440552
- DOI: 10.1097/MD.0000000000044466
Comparison of erector spinae plane block and tramadol on postoperative systemic immune-inflammatory response in breast cancer surgery: A prospective randomized controlled trial
Abstract
Background: Breast cancer is the most commonly diagnosed malignancy and the leading cause of cancer-specific deaths among women. This study aimed to compare the effects of erector spinae plane block (ESPB) and systemic tramadol use as postoperative analgesia methods on the systemic immune-inflammatory index (SII) in patients undergoing breast cancer surgery.
Methods: A total of 120 patients were included in the study and divided into 2 groups of 60 each based on the analgesia method: Group E (receiving ESPB) and Group T (receiving tramadol). SII values were measured and analyzed in both preoperative and postoperative periods.
Results: In Group T, a significant increase of 1211.78 ± 1345.34 units in postoperative SII measurements compared to the preoperative period was observed (P < .01). In Group E, a significant decrease of 498.36 ± 786.25 units in postoperative SII measurements compared to the preoperative period was noted (P < .01).
Conclusion: ESPB was found to provide more effective postoperative analgesia by reducing opioid consumption and demonstrated beneficial effects on inflammatory markers.
Trial registration: ClinicalTrials.gov NCT06954324.
Keywords: breast cancer; erector spinae plane block (ESPB); stress response; systemic immune-inflammatory index (SII).
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures
References
-
- Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313–7. - PubMed
-
- Zhang H. Cancer pain management-new therapies. Curr Oncol Rep. 2022;24:223–6. - PubMed
-
- Wang K, Wu M, Xu J, et al. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth. 2019;123:777–94. - PubMed
-
- Saeed I, La Caze A, Hollmann MW, Shaw PN, Parat MO. New insights on tramadol and immunomodulation. Curr Oncol Rep. 2021;23:123. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
